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Photodynamic therapy (PDT) is a treatmentmodality for tumours and other accessible lesions based on the combination of light and
a photosensitizer (PS) accumulated in the target tissue. The main disadvantage of PDT is PS retention after treatment during long
time periods that conduces to cutaneous damage. It is believed that singlet oxygen is responsible for that skin photosensitization.
The aim of this work was to evaluate the photoprotective activity of the methanolic extract of the Argentinian plant Collaea
argentina against PDT under several treatments and employing different PSs.C. argentina exhibited photoprotective activity against
aminolevulinic acid- (ALA-) PDT in the LM2murine adenocarcinoma cell line.The photoprotection was dependant on the extract
concentration and the incubation time, being detectable from 40𝜇g/mL onwards and at least after 3 h exposure of the cells. C.
argentina extract protects these mammalian tumor cells against PDT effects, and it interferes with the oxygen singlet production
from PSs during PDT treatment. We propose that it will be a promising agent to protect cells against PDT-induced skin sensitivity.
1. Introduction
Photodynamic therapy (PDT) is a treatment modality for
tumors and other accessible lesions. It is based on the com-
bination of light and a photosensitizer (PS), which is a light-
sensitive drug selectively accumulated in the target tissue [1].
It is widely accepted that photosensitivity is primarily
caused by the production of reactive oxygen species (ROS).
The cytotoxic effect of these species, through its reaction with
cellular targets such as proteins, lipids, and DNA, is the ratio-
nale for the use of PDT in the treatment of cancer. Most clin-
ical work on PDT has been carried out employing Photofrin,
Temoporfin, or Verteporfin, that is, porphyrin derivatives.
5-Aminolevulinic acid (ALA) has also been successfully
used as a tool for the photodiagnosis [2] and PDT of neo-
plastic tissue [3]. While ALA itself is neither fluorescent nor
a photosensitiser, it can induce the biochemical formation
of protoporphyrin IX (PpIX). Two molecules of ALA are
converted into porphobilinogen, reaction mediated by por-
phobilinogen synthase, and 5 other enzymes, 3 cytosolic and 2
mitochondrial, which lead to the formation of PpIX, which is
a very efficient photosensitizer. Photodynamic action of PpIX
ismainly induced by the generation of singlet oxygen in a type
II photodynamic reaction [4].
ALA and other PSs currently employed in clinical PDT,
such as Verteporfin and Temoporfin, produce singlet oxygen
during the light exposure and in addition all the PSs are
retained in other sites other than the tumor, thus inducing
skin photosensitivity [4–7].
Photodynamic activity of certain plant components was
first described about one hundred years ago. Bleaching of
laundry on a lawn may be the earliest practical application of
photodynamic activity. Chlorophyll, the green plant pigment,
plays the main role in the production of this photodynamic
action and, as well as some of its derivatives, it is used as a
photosensitizer in PDT [8]. In addition, the anthraquinone,
Hypericum perforatum extract, has recently been developed
as a novel and natural PS for use in PDTof cancer. An analysis
of a number of chemotherapeutic agents and their sources
reveals that over 60% of approved drugs are derived from
natural compounds [9].
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Argentina has an abundant anddiverse flora ranging from
subarctic to subtropical climates; however, the medicinal
properties of these plants have not been fully exploited. In
previouswork, we have carried out a screening ofArgentinian
plants in the search of new photosentizers (PSs) [10].
All the methanolic leaf extracts showed photoactivity due
to their chlorophyll or their derivatives content [10].However,
the extract of C. argentina leaves did not induce photodam-
age. Since this extract contains chlorophyll and its derivatives,
we hypothesised that this lack of photosensitization could be
due to the presence of photoprotective compounds. The aim
of this work was to evaluate the photoprotective activity of C.
argentina leaf extract against PDT under several conditions
using different PSs.
2. Materials and Methods
2.1. Chemicals. ALA and 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazoliumbromide (MTT) were obtained from
Sigma-Aldrich (Poole, UK). Verteporfin was obtained from
Conifarma,Argentina. Temoporfinwas obtained fromBiolite
Pharma (Ireland, UK). The rest of the chemicals employed
were of analytical grade. Chlorin e6 was from Frontier
Scientific, USA, and Toluidine blue was fromMerck.
2.2. Cell Line and Cell Culture. The cell line LM2 was derived
from a spontaneous murine mammary adenocarcinoma of
BALB/c mice. It was obtained from Instituto Roffo, Buenos
Aires, Argentina [11]. The cells were cultured in RPMI 1640
medium, supplemented with 2mM L-glutamine, 80𝜇g/mL
gentamycin, and 5% fetal bovine serum and were maintained
in a humidified atmosphere of 5% CO
2
at 37∘C.
2.3. Plant Material. Collaea argentina Griseb. (BAA 2664)
was collected from the Botanical Garden Lucien Hauman of
the Agronomy School, University of Buenos Aires, and was
identified by Ing. Agr. Juan Manuel Valla. A voucher speci-
men is kept in the herbarium of the mentioned institution.
Plant nomenclature is according to Zuloaga et al. [12].
2.4. Extraction Procedure. Fresh leaves of C. argentina (100
to 200 g) were washed with distilled water, dried, and
homogenized in absolute methanol. Methanolic extracts of
C. argentina were filtered and evaporated under reduced
pressure using a rotary evaporator and lyophilized afterwards
to remove any traces of solvent. The obtained yields were 3%
to 5%, and the resulting powders were stored at −20∘C.
2.5. PDT Treatment. The cells were exposed to the different
PSs (1mM ALA, 3mM Verteporfin, or 3mM Temoporfin)
in medium without serum. After 3 h exposure, the cells were
irradiated for different time periods employing a light source
located below the plate, at a distance of 20 cm.Afterwards, the
medium was replaced by medium containing serum and the
plates were incubated for 19 hours at 37∘C and theMTT assay
was performed.
The light source employed was a bank of two fluorescent
lamps (Osram L 36W/10). The spectrum of the light is
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Figure 1: Scheme of the different treatments designed to evaluate
the photoprotective effect of C. argentina.
between 400 and 700 nm with the highest radiant power at
600 nm. Fluence rate was measured with a Yellow Springs
Kettering model 65 radiometer (Yellow Springs, OH, USA).
We used fluences between 0 and 38mJ/cm2, corresponding
to 0 to 10min of irradiation.
2.6. Photoprotection Experiments. To test the possible pho-
toprotective activity of C. argentina, the cells were plated
at 5 × 104 cells/mL and 24 h afterwards, and they were
exposed to different concentrations of C. argentina, before,
during, and/or after PDT, according to Figure 1. C. argentina
cytotoxicity (CIXX) was defined as the concentration to kill
XX% of cells.
2.7. Singlet Oxygen Production. To detect singlet oxygen
(1O
2
), the shift of fluorescence of the fluorescent marker
“Singlet Oxygen Sensor Green” (Invitrogen, USA) was used.
The probe was added to the PSs solutions in PBS and
the mixtures were irradiated with a 635 nm Lumiia Laser
system (Buenos Aires, Argentina) coupled to a fibre optic
at 500W during different times, ranging from 2 to 10min.
The fluorescent product was quantified at 504 and 525 nm
excitation and emission wavelengths, respectively, in a Perkin
Elmer LS55 fluorometer (UK). C. argentina + PS mixtures
kept in dark were employed as controls.
2.8. MTT Viability Assay. Cytotoxicity and phototoxicity
were documented by the MTT assay [13], a method based
on the activity of mitochondrial dehydrogenases. Following
appropriate treatments, MTT (3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazoliumbromide) solution was added to each
well in a concentration of 0.5mg/mL, and plates were incu-
bated at 37∘C for 1 h. The resulting formazan crystals were
dissolved by the addition of DMSO and absorbance was read
at 560 nm.
2.9. Statistical Treatment. The values in the figures and tables
are expressed as means ± standard deviations of the means.
A two-tailed Student’s t-test was used to determine statistical
significance between means. 𝑃 values < 0.05 are considered
significant.
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Figure 2: Cytotoxicity per se of C. argentina extract in LM2 cells.
LM2 cells were incubated with C. argentina during different time
periods according to each treatment described in Section 2. Cell
death is referred as percentage of the nontreated control.
3. Results
In the first stage, we attempted to assess C. argentina dark
toxicity under the different treatments (A to D), and it
was known that the methanolic extract of C. argentina leaf
is slightly toxic to LM2 cells under darkness (CI
50
56 ±
5 𝜇g/mL) [14].
Figure 2 shows cytotoxic effects of C. argentina under
darkness (0min irradiation). During Treatment A, at low
concentrations ofC. argentina (10 and 20 𝜇g/mL), the toxicity
per se was less than 20%, and at higher concentrations
(40 and 70𝜇g/mL) C. argentina toxicity is proportionally
increased to 41% and 75%, respectively. In Treatment B,
the extract exhibits less cytotoxicity since incubation time
was decreased. In Treatment C, C. argentina cytotoxicity is
negligible since incubation time is only 10min. Treatment
D shows the highest cytotoxicity employing the highest
concentrations (40 and 70 𝜇g/mL). Treatment E involves the
longest incubation time in the presence of the extract, thus
showing evenmoremarked viability decrease. To sumup, cell
viability decreases as a function of the incubation time and
the concentration of C. argentina.
In the second stage, we evaluated the effect ofC. argentina
extract to abrogate ALA-PDT induced phototoxicity in LM2
cells (Figure 3), employing ALA-PDT conditions taken from
previous work [15].
C. argentina extract was added 24 h before photodynamic
treatment to allow cell incorporation and during ALA-PDT
(Treatment A), during ALA-PDT (Treatment B), just during
the irradiation (TreatmentC), afterALA-PDT (TreatmentD),
and before, during, and after ALA-PDT (Treatment E).
Table 1: Photoprotection indexes of C. argentina against ALA-PDT
in LM2 cells after 10min of irradiation.
C. argentina 10𝜇g/mL 20𝜇g/mL 40 𝜇g/mL 70 𝜇g/mL
Treatment A 0,02 0,10 0,92 0,84
Treatment B 0,02 0,04 0,25 0,59
Treatment C 0,02 0,02 0,17 0,21
Treatment D 0,02 0,02 0,06 0,03
Treatment E 0,02 0,06 0,69 0,74
Photoprotective indexes of C. argentina were determined as the ratios
between % cell viability after Treatment A and % cell viability after C.
argentina dark exposure, that is, without irradiation.
Figure 3 shows phototoxicity ofALA-PDT in the presence
of C. argentina, normalized to the nonirradiated control. At
low concentrations (10 and 20 𝜇g/mL) of C. argentina under
Treatment A showed no protection against ALA-PDT, but
when C. argentina concentration was increased to 70𝜇g/mL,
the percentage of living cells did not change upon irradiation,
thus suggesting a protective effect against photosensitization.
When C. argentina was added only during ALA-PDT
treatment (Treatment B), the photoprotection obtained was
lower than that observed for Treatment A. The effect was
more marked at high extract concentrations, and they
increased the amount of light dose necessary to induce a
certain percentage of cell death. That is, ALA-PDT with
10min of irradiation induced 98% of cell death in absence
of C. argentina, whereas in the presence of C. argentina,
40 𝜇g/mL and 70𝜇g/mL, the values decreased to 70% and
40%, respectively (𝑃 < 0.05).
When C. argentina was added just during the irradiation
(Treatment C), the incubation time with the cells was not
enough to allow photoprotection in all the concentration
range, showing only a slight protection at the highest con-
centrations, achieving 83% and 79% of cell death employing
40 𝜇g/mL and 70 𝜇g/mL, respectively, versus 98% of the
control (𝑃 < 0.05).
When the extract was added after ALA-PDT and with-
drawn just before MTT viability assay (Treatment D), photo-
protection was not observed in all the concentration range of
C. argentina.
In addition, when the incubation was performed before,
during, and after ALA-PDT with C. argentina (Treatment
E), the photoprotective effect was observed again, at the
highest concentrations of C. argentina, leading only to 31%
and 26%of cell death at 40 𝜇g/mL and 70 𝜇g/mL, respectively,
as compared to 98% of the control (𝑃 < 0.05).
Throughout the experiments, we noticed that the highest
concentrations of C. argentina, the highest photoprotection
indexes, independently on the treatment, employed.
We defined a photoprotection index, which allowed us
to compare the protection of each treatment, independently
on C. argentina cytotoxity (Table 1). Indexes around 1 denote
photoprotection, since they suggest no phototoxicity, whereas
values around 0 indicate no protection at all. Those indexes
let us know the best conditions to continue with our studies.
We considered that Treatment A (incubation before and
during ALA-PDT) and 40 𝜇g/mL of C. argentina would be
4 International Journal of Photoenergy
0 1 2 3 4 5 6 7 8 9 10
0
10
20
30
40
50
60
70
80
90
100
110
Vi
ab
ili
ty
 (%
 o
f t
he
 co
nt
ro
l)
Irradiation time (min)
(a)
0 1 2 3 4 5 6 7 8 9 10
0
10
20
30
40
50
60
70
80
90
100
110
Vi
ab
ili
ty
 (%
 o
f t
he
 co
nt
ro
l)
Irradiation time (min)
(b)
0 1 2 3 4 5 6 7 8 9 10
0
10
20
30
40
50
60
70
80
90
100
110
Vi
ab
ili
ty
 (%
 o
f t
he
 co
nt
ro
l)
Irradiation time (min)
(c)
0 1 2 3 4 5 6 7 8 9 10
0
10
20
30
40
50
60
70
80
90
100
110
Vi
ab
ili
ty
 (%
 o
f t
he
 co
nt
ro
l)
Irradiation time (min)
(d)
0 1 2 3 4 5 6 7 8 9 10
0
10
20
30
40
50
60
70
80
90
100
110
Vi
ab
ili
ty
 (%
 o
f t
he
 co
nt
ro
l)
Irradiation time (min)
 ALA-TFD
ALA-TFD +
ALA-TFD +
ALA-TFD +
ALA-TFD +
10𝜇g/mLC. argentina
20𝜇g/mLC. argentina
40𝜇g/mLC. argentina
70𝜇g/mLC. argentina
(e)
Figure 3: Photoprotective assays of C. argentina extract against ALA-PDT in LM2 cells. ALA-PDT was performed employing 0.6mM ALA,
3 h of incubation, and different irradiation times. ((a)–(e)) correspond to the different protocols employed, as explained in Section 2. Cell
viability was expressed as percentage of the control without irradiation.
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Figure 4: ALA-PDT of LM2 cells in the presence of C. argentina
methanolic extract or tryptophan. Cells were subjected toALA-PDT
with 0.6mMALA, 3 h of incubation, and then 10min of irradiation,
in the presence of either 40𝜇g/mLC. argentina or 8mM tryptophan
(treatment A). Viability was expressed as percentage of the control
without treatment (∗𝑃 < 0,05).
the best condition, since we obtained the higher photopro-
tective effect with the lower extract cytotoxicity.
Tryptophan is a well-known singlet oxygen scavenger and
is a photoprotective compound against ALA-PDT [15]. We
decided to compare the effect of tryptophan with the one
excerpted byC. argentina under Treatment A. Figure 4 shows
that tryptophan induces slight dark toxicity (CI
10
for 8mM
Tryptophan), and at that concentration, it abrogated ALA-
PDT effect completely. That protection was stronger than the
one obtained from C. argentina.
With the aim to know if the photoprotective effect was ex-
clusive to ALA-PDT or if it was independent on the PS used,
we evaluated the photoprotection of C. argentina against
PDT with the other two PSs of clinical use, Verteporfin and
Temoporfin which produce singlet oxygen as the main ROS
[4, 6, 7]. Figure 5 shows the effect of C. argentina against
PDT under different schemes and extract concentrations. At
low concentrations (10 and 20 𝜇g/mL) it was not possible for
the extract to excerpt photoprotection against Verteporfin or
Temoporfin-PDT.
Employing 40 𝜇g/mL and 70𝜇g/mL of the extract, a
photoprotective effect against PDT with both PSs was
observed.The highest photoprotection was excerpted against
Verteporfin-PDT, at similar rates as compared to ALA-PDT.
Cell death was reduced to 18%, which is significantly higher
than 92%observed in the control ofVerteporfin-PDTwithout
extract. For Temoporfin-PDT, similar results were obtained,
but achieving lower rates of photoprotection.
When we compared the photoprotective indexes of C.
argentina against ALA, Verteporfin, or Temoporfin-PDT, we
Table 2: Photoprotection indexes of ALA, Verteporfin, and
Temoporfin-PDT in LM2 cells.
Photosensitizer C. argentina concentration
10𝜇g/mL 20𝜇g/mL 40 𝜇g/mL 70 𝜇g/mL
ALA (PpIX) 0,02 0,10 0,92 0,84
Verteporfin 0,09 0,12 0,79 0,75
Temoporfin 0,06 0,15 0,61 0,81
Photoprotective indexes of C. argentina were determined as the ratios
between % cell viability after Treatment A and % cell viability after C.
argentina dark exposure, that is, without irradiation.
can observe that the highest indexes were obtained against
ALA-PDT (Table 2).
With the aim to test possible interferences of C. argentina
with 1O
2
production during PDT, we employed Toluidine
blue and Chlorin e6 as well-known PSs to induce a high
singlet oxygen production (Figure 6). A dramatic decrease of
1O
2
production was observed in the presence of C. argentina,
showing a direct relationship with the scavenging activity of
the extract.
4. Discussion
C. argentina protected the murine LM2 adenocarcinoma
cell line against PDT damage. The photoprotection was
dependant on the extract concentration and the incubation
time, being detectable from 40 𝜇g/mL onwards, and at least
3 h of cell exposure. Since per se cytotoxicity of the extract
interferes with the analysis of the results, it was necessary to
determine the best conditions to perform the studies, seeking
the highest photoprotection with the lowest cytotoxicity. The
best conditions were 40 𝜇g/mL of C. argentina methanolic
extract and 24 h incubation before PDT and during PDT
treatment.
Extract concentrations lower than 40 𝜇g/mL were less
toxic but, however, they did not induce photoprotection.
The highest concentration employed was 70𝜇g/mL, and even
when the photoprotection was higher, per se cytotoxicity of
C. argentina was extremely high (CI
75
).
In terms of incubation time, the strongest photoprotective
effects were observed at the longest incubation times, and
those are 24 and 48 h. However, 48 h incubation resulted in
extremely high cytotoxicity. When the extract was added just
during the irradiation or after PDT treatment, no protection
was observed, thus allowing us to think that the potential
photoprotective compound needs longer incubation times
to be taken up by the cells. This observation agrees with a
previous work of our group [15] where compounds like L-
tryptophan, N-acetyl-L-cystein, melatonin, L-methionine, L-
cystein, mannitol, and glycine incubated before and during
PDT treatment showed the best photoprotective effects. The
photoprotection of C. argentina was comparable with that of
tryptophan, which is a well-known oxygen singlet scavenger
[15].
C. argentina protection against Verteporfin and Temo-
porfin-PDT was also observed at a lesser extent as com-
pared to ALA-PDT. PpIX from ALA and Verteporfin are
6 International Journal of Photoenergy
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Figure 5: Photoprotection assays of C. argentina against Verteporfin and Temoporfin-PDT. LM2 cells were incubated 3 h with 3mM
Verteporfin (a) or 3mM Temoporfin (b), and C. argentina was added before and during PDT (Treatment A). Viability was expressed as
percentage with respect to the nonirradiated control.
accumulatedmainly inmitochondria and plasmamembrane.
Verteporfin in addition is accumulated in the endoplas-
matic reticle. Temoporfin accumulates in Golgi apparatus,
endoplasmatic reticle, and at minor levels, in mitochon-
dria [16–18]. The highest photoprotection against ALA and
Verteporfin-mediated PDTmay be related to their subcellular
localization sites.
Not always the antioxidant defenses can cope with the
entire PDT damage. It was reported that nasopharyngeal
tumor cells that overexpress metallothioneins, which act as
free radicals scavengers, were overcome by hypericin-PDT.
Hypericin is a PS extract from a plant, which produces
O
2
− and 1O
2
, and upon irradiation induces necrosis in the
mentioned cells [19].
Few authors reported photoprotection against PDT.
Nitroimidazoles were found to be photoprotectors against
PDT using Photofrin, in the emt-6 mammalian murine
tumor cell line [20]. In vivo studies demonstrated that 1,3
diphenyl-benzofuran and tryptophan were photoprotective
compounds in rats treated with PDT using hematoporphyrin
as PS [21].
A disadvantage of PDT is the PS retention in sites other
than tumor during long time periods after treatment, even
weeks, which induces skin photosensitivity. In vitro and in
vivo studies describe that singlet oxygen is responsible for
cutaneous photosensitization. It is highly important to find
compounds to reduce adverse effects of PDT.
Plants have biochemical systems that attenuate the harm-
ful effects of reactive oxygen species, in particular those
generated during the photosynthesis, and xanthophylls and
carotenoids account for these antioxidant defenses involved.
Other compounds are able to synthesize molecules which
respond to biotic and abiotic stress, commonly called
secondary metabolites. Some of these compounds have
been reported as photoprotectors and/or antioxidants. Beta-
carotene and flavonoids usually are in chloroplastmembranes
to protect the damage caused by 1O
2
, in a particular way to
protect against lipid photoperoxidation. Scavenger effects of
lipid plant extracts against 1O
2
were detected [22].
Polyphenols synthesized in higher plants, in response to
stress, constitute also part of their antioxidant defense system
[23]. Curcumin extracted from Curcuma longa is able to
inhibit the apoptosis generated by oxidant damage of 1O
2
during PDT treatment in A431 epidermoid carcinoma cells
[24].
UV and psoralen therapy is a kind of photochemotherapy
which uses UV radiation instead of visible light as it is used
in PDT. The use of plant extracts for UV protection is wildly
known. The extract of Polypodium leucotomos administrated
orally or topically, resulted in photoprotection in Langerhans
cells against UV and psoralens employed in vitiligo treatment
[25].
Employing qualitative tests to identify organic mole-
cule functional groups, we detected the presence of anthra-
quinones, saponins, carbohydrates, and tanins inC. argentina
extract. However, we do not know the exact composition
of C. argentina and its relationship with its photoprotective
properties.
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Figure 6: C. argentina as scavenger of singlet oxygen produced by
Toluidine blue and Chlorin e6-PDT. Singlet oxygen production was
quantified using a fluorescent specific probe at different times of
PDT employing Toluidine blue and Chlorin e6 as photosensitizers.
To sum up, our results indicate that C. argentina extract
protects mammalian tumor cells against PDT effects, and it
interferes with singlet oxygen production during photody-
namic treatment. We propose this will be a promising agent
to protect skin from adverse photosensitivity. It is our hope to
continue this work with in vivo studies and purification of the
extract with the aim to isolate the compound responsible for
the photoprotection and further studies in normal skin tissue
are needed to ascertain that the plant C. argentina may be
employed in the prevention from side effects caused by PDT.
Our findings would be useful in the design of ointments to
protect normal skin against the undesirable effects of PDT.
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